Trial Profile

Multicenter, Single-blind, Adaptive Dose Finding Study of Single Intravenous Injections of BAY 1747846 With Corresponding Blinded Read in Adult Participants With Known or Highly Suspected CNS Lesions Referred for Contrast-enhanced MRI of the CNS

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

26 Jan 2026 According to a Bayer media release, results from this trial will be presented at the 2026 European Congress of Radiology (ECR) taking place from March 4-8, 2026, in Vienna, Austria.
22 Nov 2023 According to a Bayer media release, results from this trial will be presented at the 2023 Radiological Society of North America (RSNA) Annual Meeting, taking place from November 26 to 30 in Chicago, USA.
13 Dec 2022 Status changed from recruiting to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com